polaris retatrutide news october 2025 Demand for Unapproved Weight-Loss Drug Surges on Social Media New weight loss drug dubbed
Description
Ro Body vs TrimRx: which GLP-1 program is better in 2026
The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.
The key to future success will be adapting product selections and marketing to line up with the new health-focused mindset of this growing group of shoppers...
Bristol Myers, Eli Lilly also warned.
Losing weight can be a really difficult journey for many, and with the advent of GLP-1 weight loss drugs, there
Retention of glucagon function is required to achieve such an advantage over GLP-1 monotherapy
